About Deepro R. Mukerjee
Deepro R. Mukerjee is the national co-chair of Katten's Patent Litigation practice and is a member of the firm’s Board of Directors. He represents the world's largest generic pharmaceutical companies in Hatch-Waxman cases throughout the country. His work on these critical cases is part of a larger practice advising numerous multi-national companies (pharmaceutical and otherwise) on their respective IP needs – particularly when it comes to "bet the company" litigations. Deepro is a first chair litigator, and has tried bench and jury trials across the country.
Hatch-Waxman litigation and more
Deepro has been lead trial counsel in dozens of Hatch-Waxman cases, often taking them to trial and subsequent appeals. He is also experienced at handling inter partes review proceedings before the Patent Trial and Appeal Board. While his focus is in the pharmaceutical and life sciences arena, Deepro's litigation experience is more expansive and covers matters related to biotechnology, botanicals, electrical circuit interrupting devices and voice recognition software.
Practice Focus
- Hatch-Waxman and bio-similars litigation
- Intellectual property litigation
- Patent litigation
- Corporate IP Counseling
Representative Experience
News
-
December 10, 2020
-
November 20, 2020
-
August 19, 2020
-
June 22, 2020
-
June 2, 2020
-
May 13, 2020
-
May 1, 2020
-
March 16, 2020
-
August 29, 2019
- View All News
Publications
-
November 24, 2020
-
August 5, 2020
-
May 19, 2020
-
January 25, 2019
Presentations and Events
-
Panelist | The Economics and Economy of Drug Patents with ACI’s Hatch-Waxman Series Advisory Board Members: Optimizing Product Selection, Identifying Targets for Litigation and Monetizing IP PortfoliosApril 26–27, 2021
-
Panelist | In-House Perspectives on The Future of IP Teams and Working with Outside CounselOctober 6–7, 2020